Dendritic cell FcεR1 expression is rapidly down-regulated with omalizumab
Year: 2003
Type: article
Study design: Clinical Trial
Authors: D.T. Griffith, K.M. Boesel, C. Prussin, B. Foster, H. Lin, T.B. Casale
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2067159762
